HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Research Dictionary Pharma Mobile

Sign Up FREE or Login

afutuzumab

Subscribe to New Research on afutuzumab

anti-CD20 mAb for treating B-cell lymphoid cancers

Also Known As:

GA 101; GA-101; GA101 antibody; R 7159; R-7159; R7159 cpd; RO 5072759; RO-5072759; RO5072759

Networked: 1 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins
- Proteins: 90489
  - Blood Proteins: 4303
    - Serum Globulins: 75
      - Immunoglobulins: 23980
        Antibodies: 92632
        Monoclonal Antibodies: 18549
        afutuzumab: 1
    - Immunoproteins: 33
      - Immunoglobulins: 23980
        Antibodies: 92632
        Monoclonal Antibodies: 18549
        afutuzumab: 1
  - Globulins: 334
    - Serum Globulins: 75
      - Immunoglobulins: 23980
        Antibodies: 92632
        Monoclonal Antibodies: 18549
        afutuzumab: 1

Experts

1.	Robak, Tadeusz: 1 article (06/2009)

Related Diseases

1.	Neoplasms (Cancer) 06/01/2009 - "In preclinical studies, GA-101 was significantly more potent and effective in depleting B-cells than rituximab, and induced dose-dependent antitumor activity, complete tumor regression and improved long-term survival in xenograft mouse models of B-cell malignancy. "
2.	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/01/2009 - "Based on preclinical and preliminary clinical data, GA-101 appears to be a promising therapeutic agent for CD20-positive B-cell lymphoid malignances, including non-Hodgkin lymphomas and chronic lymphocytic leukemia."
3.	Lymphoma (Lymphomas) 06/01/2009 - "Based on preclinical and preliminary clinical data, GA-101 appears to be a promising therapeutic agent for CD20-positive B-cell lymphoid malignances, including non-Hodgkin lymphomas and chronic lymphocytic leukemia."

Related Drugs and Biologics

1.	rituximab (Mabthera)

Related Therapies and Procedures

1.	Heterologous Transplantation (Xenotransplantation)